Yantai, China

Qilin Wang

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 6.0

ph-index = 1


Location History:

  • Shandong, CN (2014)
  • Yantai, CN (2016 - 2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Qilin Wang from Yantai, China

Introduction

Qilin Wang, an accomplished inventor based in Yantai, China, has made notable contributions in the field of pharmaceutical innovation. With five patents to his name, Wang’s work primarily focuses on advancements in drug delivery systems, enhancing the efficacy and stability of pharmaceutical formulations.

Latest Patents

One of Wang's latest patents is a risperidone sustained release microsphere composition. This innovative formulation comprises risperidone or its derivative, 9-hydroxy risperidone, in combination with a unique polymer blend. This blend consists of two uncapped lactide-glycolide copolymers, each with different intrinsic viscosities. The high intrinsic viscosity copolymer offers enhanced stability, while the low intrinsic viscosity variant ensures a favorable in vivo release behavior that remains consistent even after extended storage. This formulation is designed for large-scale industrial manufacturing, addressing critical needs in the pharmaceutical industry.

Career Highlights

Qilin Wang has a rich professional background associated with prestigious pharmaceutical organizations. He has worked at Shandong Luye Pharmaceutical Co., Ltd. and Nanjing Luye Pharmaceutical Co., Ltd., contributing significantly to their research and development efforts. His expertise in formulation chemistry has established him as a pivotal figure in advancing therapeutic technologies.

Collaborations

Throughout his career, Wang has collaborated with notable colleagues, including Kaoxiang Sun and Rongcai Liang. These partnerships have further fueled innovation, allowing for a collective push toward improving drug formulations and delivery systems.

Conclusion

Qilin Wang continues to be a driving force in pharmaceutical innovation from his base in Yantai, China. Through his sustained release microsphere compositions and strategic collaborations, he emphasizes the importance of research in creating effective and stable pharmaceutical products, paving the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…